Immunonutrition with L-citrulline for ICU sepsis patients
Part of Infections clinical trials.
This trial tests whether adding L-citrulline to tube feeding (enteral nutrition) can improve outcomes for people in the ICU with sepsis or septic shock. It may help support the body’s immune response while you’re critically ill.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in the ICU for sepsis or septic shock, diagnosed by accepted 2016 criteria.
- Your infection symptoms started less than 4 days before ICU admission.
- You have been in the hospital less than 48 hours before ICU admission.
- You need a breathing machine (invasive mechanical ventilation) and it is expected to last more than 2 days.
- You can receive nutrition through a feeding tube only (exclusive enteral nutrition).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a metabolite (nutrient) supplement can help the body’s cells work better when someone is in septic shock. It is done in the ICU, and it may benefit people with sepsis who still have poor circulation and high lactate levels despite standard treatment.
This trial tests if curcumin (a natural compound found in turmeric) can help critically ill patients fighting sepsis, a life-threatening response to infection. It is for adults who are already receiving food through a feeding tube in the ICU.
This trial tests whether a combination of vitamins B6, B12, and C can help improve blood flow in tiny blood vessels (microcirculation) for people with sepsis. It may help your body recover better from severe infection.
This trial tests if the type of tube feeding given to sepsis patients in the ICU can affect their recovery. It aims to find the best diet to help fight the infection and prevent complications.
This study tests whether a personalized nutrition formula can improve outcomes for critically ill patients in the ICU. It aims to see if tailored nutrition helps with recovery and overall health.
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.